XML 34 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated statement of cash flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Cash flows from operating activities      
Profit before tax $ 10,839 $ 4,459 $ 4,318
Adjustments for non-cash items:      
Depreciation, amortisation and impairment 1,802 2,146 3,095
Net gain from investing activities (485) (136) (405)
Share of profits in associates and joint ventures (1,656) (639) (958)
Change in expected credit losses gross of recoveries and other credit impairment charges (484) 2,221 6,875
Provisions including pensions 301 887 277
Share-based payment expense 254 238 195
Other non-cash items included in profit before tax 205 (188) (718)
Change in operating assets (3,811) (23,788) 11,185
Change in operating liabilities 49,015 68,164 134,734
Elimination of exchange differences [1] 5,212 (29,524) 3,775
Dividends received from associates 10 641 120
Contributions paid to defined benefit plans (342) (160) (335)
Tax paid (997) (1,886) (2,373)
Net cash from operating activities 59,863 22,435 159,785
Cash flows from investing activities      
Purchase of financial investments (263,198) (224,839) (271,830)
Proceeds from the sale and maturity of financial investments 298,596 251,257 225,733
Net cash flows from the purchase and sale of property, plant and equipment (375) (999) (447)
Net cash flows from purchase of customer and loan portfolios 1,063 1,118 244
Net investment in intangible assets (1,011) (1,107) (957)
Net cash flow on (purchase)/disposal of subsidiaries, businesses, associates and joint ventures (84) (194) (409)
Net cash from investing activities 34,991 25,236 (47,666)
Cash flows from financing activities      
Issue of ordinary share capital and other equity instruments 1,996 1,497 0
Net sales/(purchases) of own shares for market-making and investment purposes 1 (133) (48)
Redemption of preference shares and other equity instruments (3,450) 0 (398)
Subordinated loan capital repaid (852) (2,000) (1,538)
Dividends paid to shareholders of the parent company and non-controlling interests (4,121) (819) (1,204)
Net cash from financing activities (6,426) (1,455) (3,188)
Net increase/(decrease) in cash and cash equivalents 88,428 46,216 108,931
Cash and cash equivalents at the beginning of the period 468,323 395,218 293,742
Exchange differences in respect of cash and cash equivalents (4,818) 26,889 (7,455)
Cash and cash equivalents at the end of the period $ 551,933 $ 468,323 $ 395,218
[1] Adjustments to bring changes between opening and closing balance sheet amounts to average rates. This is not done on a line-by-line basis, as details cannot be determined without unreasonable expense.